MC
WST icon

Moors & Cabot’s West Pharmaceutical WST Stock Holding History

Moors & Cabot’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-844
Closed -$255K – 874
2022
Q2 		$255K Sell
844
-5
-0.6% -$1.63K 0.02% 614
2022
Q1 		$349K Buy
849
+300
+55% +$117K 0.02% 590
2021
Q4 		$257K Buy
+549
New +$236K 0.02% 688

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moors & Cabot's WST Position: Q3 2022 in Review

Moors & Cabot sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 844 shares — an estimated $255K sold.

Moors & Cabot first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $349K in Q1 2022. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Moors & Cabot reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Moors & Cabot sold 844 West Pharmaceutical shares in Q3 2022, an estimated $255K.
  • Moors & Cabot first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • Moors & Cabot's West Pharmaceutical position peaked at $349K in Q1 2022.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Moors & Cabot's 13F filing for Q3 2022, filed 8 Nov 2022.